Companies: 10,795·Total market cap: $144.5T
Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals Inc.

EPRX.TOTSXHealthcare● Active
$8.46
+$0.13(+1.56%)
Market Cap$304031539
P/E Ratio—
52W High$12.86
52W Low$5.2
ForecastMarket CapPE Ratio

Eupraxia Pharmaceuticals Inc.（EPRX.TO）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

eprx.to · 股价预测 · 2 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 2 位华尔街分析师

SellBuy

Buy

2 位分析师

共识

评级分布

Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
合计: 2 · 买入占比: 100.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $8.33

Eupraxia Pharmaceuticals Inc.（EPRX.TO）的分析师共识为 Buy，基于过去 3 个月内 2 位华尔街分析师的评级。EPRX.TO 的 12 个月平均目标价为 $0.00，相对当前价 $8.33 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$7.94↓ 4.66%

1-day model range: $7.88–$8. Peak: $8 (-4.66%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$6-24.1%
2028$5-34.2%
2029$5-39.0%
2030$5-41.4%
2031—-42.7%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)38.6Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · EPRX.TO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$9.01SELL
MA 10$9.57SELL
MA 20$9.67SELL
MA 50$9.80SELL
MA 100$10.51SELL
MA 200$9.50SELL
Current $EPRX.TO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$8.96SELL
EMA 10$9.28SELL
EMA 20$9.55SELL
EMA 50$9.85SELL
EMA 100$9.91SELL
EMA 200$9.31SELL
Current $EPRX.TO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-05-04
Maintains
Buy→Buy
HC Wainwright & Co.2026-04-22
Maintains
Buy→Buy
HC Wainwright & Co.2026-03-17
Maintains
Buy→Buy
Cantor Fitzgerald2026-01-15
Maintains
Overweight→Overweight
HC Wainwright & Co.2026-01-09
Maintains
Buy→Buy
HC Wainwright & Co.2025-08-20
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on Eupraxia Pharmaceuticals Inc. (EPRX.TO) stock. Of the recent 6 rating actions, 0 were upgrades and 0 were downgrades. 2 analysts currently cover EPRX.TO.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

EPRX.TO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$16M

↑ 64.8% YoY

Revenue Next Year

$16M

↓ 0.1% YoY

EPS This Year

$-1.17

EPS Next Year

$-1.18

↑ 1.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EPRX.TO EPS of $-1.17 for the current fiscal year, based on estimates from 5 analysts. The EPRX.TO revenue forecast is $16M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

EPRX.TO 股价预测由两类独立数据源支撑：来自 2 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。EPRX.TO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

EPRX.TO 的短期预测（明日）为 $7.94（-4.66%）。 EPRX.TO 对 2027 年的股价预测均值为 $6。 EPRX.TO 对 2030 年的预测区间为 $4–$5。

Eupraxia Pharmaceuticals Inc. 在 TSX 上市，代码 EPRX.TO。EPRX.TO 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

EPRX.TO 预测 · 8 个问题

根据 2 位华尔街分析师，EPRX.TO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $8.33，隐含约 +0.0% 的上行空间。

EPRX.TO 目标价EPRX.TO 分析师目标价EPRX.TO 12个月目标价目标价 EPRX.TO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.